Companies have produced natural products such as cannabinoids via biosynthesis, or cellular agriculture, for decades. Cellular agricultural is the process of producing chemicals using microorganisms such as yeast, and it can produce cannabinoids at a purity that’s greater than 99% – and in less time and at a lower cost than plant-based production. Once commercialized, these technologies could disrupt the cannabis industry. Should growers worry? Will cannabinoids be grown in a field or a laboratory? Dr. Jason Poulos, CEO of Librede, which produces cannabinoids with yeast, will answer critical questions exploring this new frontier where biotechnology and cannabis meet.
In this session, you’ll gain insights on:
- The current state of cannabinoid production by microorganisms
- How microorganisms can be used to produced therapeutic properties at scale
- Agricultural production verses biosynthetic production